1,060
Views
10
CrossRef citations to date
0
Altmetric
Report

Trends in capacity utilization for therapeutic monoclonal antibody production

Pages 151-156 | Received 01 Dec 2008, Accepted 08 Jan 2008, Published online: 01 Mar 2009

Figures & data

Figure 1 Average production as percent of operating capacity, by system, 2007, 2006, 2005 and 2003.

Figure 1 Average production as percent of operating capacity, by system, 2007, 2006, 2005 and 2003.

Figure 2 Capacity constraints 2007, by stage of production.

Figure 2 Capacity constraints 2007, by stage of production.

Figure 3 Planned future capacity expansion: 5-year estimates, 2008 through 2012, biotherapeutic developers vs. CMOs.

Figure 3 Planned future capacity expansion: 5-year estimates, 2008 through 2012, biotherapeutic developers vs. CMOs.

Figure 4 Planned future capacity expansions: 5-year estimates, 2008 through 2012, US vs Western Europe.

Figure 4 Planned future capacity expansions: 5-year estimates, 2008 through 2012, US vs Western Europe.

Figure 5 Factors creating future capacity constraints.

Figure 5 Factors creating future capacity constraints.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.